Evidence check: Glukose in the context of Langlebigkeit

The provided context does not contain direct evidence on glucose in relation to longevity. Generally, chronically elevated fasting glucose and HbA1c are associated with accelerated biological aging and increased risk of age-related diseases such as type 2 diabetes, cardiovascular disease, and cognitive decline. Evidence comes from large epidemiological cohorts and intervention studies (e.g., caloric restriction, metformin). However, translation to individual 'longevity' is limited because glucose homeostasis is only one factor among many. Consumer tests claiming 'glucose management' or 'insulin resistance' often rely on insufficiently validated markers (e.g., HbA1c alone) and do not provide clinical diagnoses. Caveat: Without medical interpretation, such results can lead to unnecessary anxiety or misguided dietary changes. Evidence grade: human-moderate (for the link between glucose control and healthy aging), but marketing (for many direct consumer claims).